VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 132 filers reported holding VERASTEM INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,495 | +11.9% | 20,459 | +8.4% | 0.00% | – |
| Q4 2022 | $7,593 | -93.2% | 18,865 | -85.6% | 0.00% | – |
| Q3 2022 | $111,000 | -67.4% | 130,856 | -55.5% | 0.00% | – |
| Q2 2022 | $341,000 | -25.4% | 294,045 | -9.2% | 0.00% | – |
| Q1 2022 | $457,000 | -19.3% | 323,731 | +17.3% | 0.00% | – |
| Q4 2021 | $566,000 | -70.9% | 275,959 | -56.2% | 0.00% | – |
| Q3 2021 | $1,942,000 | +33.0% | 630,500 | +75.7% | 0.00% | – |
| Q2 2021 | $1,460,000 | +12.3% | 358,852 | -31.8% | 0.00% | – |
| Q1 2021 | $1,300,000 | -10.4% | 526,309 | -22.7% | 0.00% | – |
| Q4 2020 | $1,451,000 | +458.1% | 681,207 | +216.8% | 0.00% | – |
| Q3 2020 | $260,000 | +430.6% | 215,028 | +646.1% | 0.00% | – |
| Q2 2020 | $49,000 | -83.7% | 28,822 | -74.7% | 0.00% | – |
| Q1 2020 | $300,000 | +36.4% | 113,698 | -30.8% | 0.00% | – |
| Q4 2019 | $220,000 | +315.1% | 164,400 | +275.1% | 0.00% | – |
| Q3 2019 | $53,000 | -82.8% | 43,829 | -78.6% | 0.00% | – |
| Q2 2019 | $308,000 | -65.4% | 204,402 | -32.0% | 0.00% | – |
| Q1 2019 | $889,000 | +38.5% | 300,623 | +57.4% | 0.00% | – |
| Q4 2018 | $642,000 | -51.1% | 190,984 | +5.5% | 0.00% | – |
| Q3 2018 | $1,312,000 | -12.8% | 180,953 | -17.2% | 0.00% | – |
| Q2 2018 | $1,504,000 | +916.2% | 218,645 | +340.5% | 0.00% | – |
| Q1 2018 | $148,000 | +102.7% | 49,636 | +109.2% | 0.00% | – |
| Q4 2017 | $73,000 | +4.3% | 23,731 | +58.6% | 0.00% | – |
| Q3 2017 | $70,000 | +75.0% | 14,965 | -17.7% | 0.00% | – |
| Q2 2017 | $40,000 | -2.4% | 18,192 | -8.7% | 0.00% | – |
| Q1 2017 | $41,000 | -41.4% | 19,920 | -68.1% | 0.00% | – |
| Q4 2016 | $70,000 | +40.0% | 62,413 | +66.2% | 0.00% | – |
| Q3 2016 | $50,000 | -26.5% | 37,562 | -27.8% | 0.00% | – |
| Q2 2016 | $68,000 | +78.9% | 51,997 | +114.9% | 0.00% | – |
| Q1 2016 | $38,000 | -87.6% | 24,195 | -85.3% | 0.00% | – |
| Q4 2015 | $307,000 | +219.8% | 164,828 | +206.7% | 0.00% | – |
| Q3 2015 | $96,000 | -42.2% | 53,744 | +195.8% | 0.00% | – |
| Q4 2014 | $166,000 | +4.4% | 18,167 | +30.0% | 0.00% | – |
| Q4 2013 | $159,000 | +12.8% | 13,972 | +37.1% | 0.00% | – |
| Q2 2013 | $141,000 | +48.4% | 10,189 | +0.3% | 0.00% | – |
| Q3 2012 | $95,000 | – | 10,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |